Form 4: Nuvalent CEO James Richard Porter Sells Shares Under 10b5-1 Trading Plan

Nuvalent's CEO, James Richard Porter, executed multiple sales of Class A Common Stock on April 15, 2025, under a pre-arranged Rule 10b5-1 trading plan.

Summary

• On April 15, 2025, James Richard Porter, the President and CEO of Nuvalent, Inc., sold shares of Class A Common Stock.
• The sales were executed under a Rule 10b5-1 trading plan adopted on April 2, 2024.
• A total of 27,000 shares were acquired through the exercise of stock options at a price of $27.85 per share.
• Simultaneously, 10,987 shares were sold at a weighted average price of $68.31, 11,060 shares at $69.05, 4,465 shares at $70.05, and 488 shares at $70.73.
• Following these transactions, Porter directly owns 249,062 shares of Class A Common Stock and holds options for 231,780 shares.

Sentiment

Score: 5

Explanation: The sentiment is neutral as the transactions are part of a pre-planned trading strategy. It doesn't necessarily indicate a positive or negative outlook on the company's future.

Industry Context

Executive stock sales are a common occurrence in publicly traded companies and are often conducted under pre-arranged trading plans like Rule 10b5-1 to avoid accusations of insider trading. The market typically analyzes these sales in the context of the executive's overall holdings and the company's performance.

Comparison to Industry Standards

• Executive compensation and trading activities are closely monitored across the pharmaceutical and biotechnology industries.
• Companies like Amgen, Gilead Sciences, and Vertex Pharmaceuticals have similar reporting requirements for insider transactions.
• The use of 10b5-1 trading plans is a standard practice among executives to manage their stock holdings while complying with insider trading regulations.
• The size and frequency of these transactions are often compared to industry benchmarks to assess whether they are typical or indicative of a particular sentiment regarding the company's future prospects.

Stakeholder Impact

• Shareholders may interpret the stock sale as a lack of confidence from the CEO, although it's part of a pre-arranged plan.
• The transactions could have a minor impact on the stock price due to the volume of shares sold.

Key Dates

Keywords

Nuvalent, James Richard Porter, NUVL, Form 4, Stock Sale, Rule 10b5-1, Insider Trading, CEO, Class A Common Stock, Equity